FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804082663> ?p ?o ?g. }

• W2804082663 endingPage "25982" @default.
• W2804082663 startingPage "25971" @default.
• W2804082663 abstract "We prospectively examined whether surface expression of Cytokine Receptor-Like Factor 2 (CRLF2) on leukemic blasts is associated with survival and induction treatment response in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Flow cytometric analysis of bone marrow-derived leukemia cells revealed that 7.51% (29/286) of 386 pediatric BCP-ALL patients were CRLF2-positive (CRLF2pos) at diagnosis. The median minimal residual disease (MRD) was lower in CRLF2pos than CRLF2-negative (CRLF2neg) patients on day 15 (MRD15) after induction therapy [0.01% (0.001-0.42%) vs. 0.45% (0.05-3.50%); p=0.001]. By contrast, the MRD15 was higher in Ikaros family Zinc Finger Protein 1 (IKZF1)-deleted BCP-ALL patients than in BCP-ALL patients without IKZF1 deletions [1.18% (0.06-12.0%) vs 0.33% (0.03-2.6%); p=0.003]. Subgroup analysis showed that MRD15 levels were lower in IKZF1Δ/CRLF2pos patients than in IKZF1Δ/CRLF2neg patients [0.1% (0.02-5.06%) vs. 2.9% (0.25-12%); p=0.005]. Furthermore, MRD15 levels were higher in IKZF1WT/CRLF2neg patients than in IKZF1WT/CRLF2pos patients [0.40% (0.04-2.7%) vs. 0.001% (0.001-0.01%)]. Despite the low MRD15 levels, IKZF1Δ/CRLF2pos patients showed poorer relapse-free survival (RFS) than other patient groups (p=0.003). These findings demonstrate that surface CRLF2 expression is associated with increased risk of relapse in pediatric BCP-ALL patients harboring IKZF1 deletions." @default.
• W2804082663 created "2018-06-01" @default.
• W2804082663 creator A5001980965 @default.
• W2804082663 creator A5004662081 @default.
• W2804082663 creator A5019262446 @default.
• W2804082663 creator A5020975466 @default.
• W2804082663 creator A5027562779 @default.
• W2804082663 creator A5030870747 @default.
• W2804082663 creator A5032421357 @default.
• W2804082663 creator A5032424111 @default.
• W2804082663 creator A5032725451 @default.
• W2804082663 creator A5037437881 @default.
• W2804082663 creator A5042237464 @default.
• W2804082663 creator A5046777203 @default.
• W2804082663 creator A5058156879 @default.
• W2804082663 creator A5058731031 @default.
• W2804082663 creator A5059866558 @default.
• W2804082663 creator A5061002491 @default.
• W2804082663 creator A5062062146 @default.
• W2804082663 creator A5064746136 @default.
• W2804082663 creator A5066904813 @default.
• W2804082663 creator A5068243958 @default.
• W2804082663 creator A5069409688 @default.
• W2804082663 creator A5071752621 @default.
• W2804082663 creator A5076714732 @default.
• W2804082663 creator A5084249791 @default.
• W2804082663 creator A5090154232 @default.
• W2804082663 creator A5091190295 @default.
• W2804082663 date "2018-05-25" @default.
• W2804082663 modified "2023-10-12" @default.
• W2804082663 title "Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring <i>IKZF1</i> deletions" @default.
• W2804082663 cites W1984684983 @default.
• W2804082663 cites W1994700885 @default.
• W2804082663 cites W2000266274 @default.
• W2804082663 cites W2012114257 @default.
• W2804082663 cites W2034920499 @default.
• W2804082663 cites W2036999612 @default.
• W2804082663 cites W2059520874 @default.
• W2804082663 cites W2071700698 @default.
• W2804082663 cites W2072434377 @default.
• W2804082663 cites W2073878519 @default.
• W2804082663 cites W2082890836 @default.
• W2804082663 cites W2087296000 @default.
• W2804082663 cites W2089445567 @default.
• W2804082663 cites W2090630520 @default.
• W2804082663 cites W2090932554 @default.
• W2804082663 cites W2092157777 @default.
• W2804082663 cites W2096709475 @default.
• W2804082663 cites W2102365540 @default.
• W2804082663 cites W2110032977 @default.
• W2804082663 cites W2140148690 @default.
• W2804082663 cites W2148202982 @default.
• W2804082663 cites W2158932180 @default.
• W2804082663 cites W2307154186 @default.
• W2804082663 cites W2557296082 @default.
• W2804082663 cites W2558502346 @default.
• W2804082663 cites W2726804531 @default.
• W2804082663 cites W4238542615 @default.
• W2804082663 cites W4250063037 @default.
• W2804082663 doi "https://doi.org/10.18632/oncotarget.25411" @default.
• W2804082663 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5995260" @default.
• W2804082663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29899835" @default.
• W2804082663 hasPublicationYear "2018" @default.
• W2804082663 type Work @default.
• W2804082663 sameAs 2804082663 @default.
• W2804082663 citedByCount "13" @default.
• W2804082663 countsByYear W28040826632019 @default.
• W2804082663 countsByYear W28040826632020 @default.
• W2804082663 countsByYear W28040826632021 @default.
• W2804082663 countsByYear W28040826632022 @default.
• W2804082663 countsByYear W28040826632023 @default.
• W2804082663 crossrefType "journal-article" @default.
• W2804082663 hasAuthorship W2804082663A5001980965 @default.
• W2804082663 hasAuthorship W2804082663A5004662081 @default.
• W2804082663 hasAuthorship W2804082663A5019262446 @default.
• W2804082663 hasAuthorship W2804082663A5020975466 @default.
• W2804082663 hasAuthorship W2804082663A5027562779 @default.
• W2804082663 hasAuthorship W2804082663A5030870747 @default.
• W2804082663 hasAuthorship W2804082663A5032421357 @default.
• W2804082663 hasAuthorship W2804082663A5032424111 @default.
• W2804082663 hasAuthorship W2804082663A5032725451 @default.
• W2804082663 hasAuthorship W2804082663A5037437881 @default.
• W2804082663 hasAuthorship W2804082663A5042237464 @default.
• W2804082663 hasAuthorship W2804082663A5046777203 @default.
• W2804082663 hasAuthorship W2804082663A5058156879 @default.
• W2804082663 hasAuthorship W2804082663A5058731031 @default.
• W2804082663 hasAuthorship W2804082663A5059866558 @default.
• W2804082663 hasAuthorship W2804082663A5061002491 @default.
• W2804082663 hasAuthorship W2804082663A5062062146 @default.
• W2804082663 hasAuthorship W2804082663A5064746136 @default.
• W2804082663 hasAuthorship W2804082663A5066904813 @default.
• W2804082663 hasAuthorship W2804082663A5068243958 @default.
• W2804082663 hasAuthorship W2804082663A5069409688 @default.
• W2804082663 hasAuthorship W2804082663A5071752621 @default.
• W2804082663 hasAuthorship W2804082663A5076714732 @default.
• W2804082663 hasAuthorship W2804082663A5084249791 @default.
• W2804082663 hasAuthorship W2804082663A5090154232 @default.
• W2804082663 hasAuthorship W2804082663A5091190295 @default.

• next